Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Atherosclerosis Pubmed

Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

Download PDF

Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

Cawood, Abbie L; Ding, Ren; Napper, Frances L; Young, Ruth H; Williams, Jennifer A; Ward, Matthew J A; Gudmundsen, Ola; Vige, Runar; Payne, Simon P K; Ye, Shu; Shearman, Ciff P; Gallagher, Patrick J; Grimble, Robert F; Calder, Philip C
Atherosclerosis , Volume 212 (1): -242 – Dec 28, 2010

Loading next page...
 
/lp/pubmed/eicosapentaenoic-acid-epa-from-highly-concentrated-n-3-fatty-acid-bTRHaZqFlp

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0021-9150
DOI
10.1016/j.atherosclerosis.2010.05.022
pmid
20542512

Abstract

Journal

Atherosclerosis – Pubmed

Published: Dec 28, 2010

There are no references for this article.